Clinical Trial

Analgesic Effects of Combined Nalbuphine-bupivacaine Versus Dexamethasone-bupivacaine in Pericapsular Nerve Group Block (PENG) After Hip Surgeries: A Randomized Clinical Study

Study acronym: PENG
Completed
View on ClinicalTrials.gov →
Summary
The aim of the study to Evaluate the efficacy of nalbuphine-bupivacaine vs dexamethasone-bupivacaine in ultrasound guided pericapsular nerve group (PENG) block for improving pain management, reducing opioid consumption, and enhancing the overall analgesic effect in patients undergoing hip surgeries.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-14.
Status change: Recruiting → Completed 2026-01-21
Trial Details
NCT Number NCT06972654
Lead Sponsor Zagazig University
Conditions Analgesia, Postoperative
Enrollment 102 participants
Start Date 2025-04-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-23